PG

Procter & Gamble Declares $1.0065 Quarterly Dividend

The Procter & Gamble Company (NYSE:PG) has declared a quarterly dividend of $1.0065 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company. This dividend is payable on or after November 15, 2024, to Common Stock shareholders of record at the close of business on October 18, 2024, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 18, 2024.

P&G has a long history of paying dividends, having done so for 134 consecutive years since its incorporation in 1890. Moreover, the company has increased its dividend for 68 consecutive years, demonstrating its commitment to returning cash to shareholders.

At the 2024 Annual Meeting of Shareholders, all 14 P&G Director nominees were elected, with each receiving strong support according to preliminary voting results. The final results of the vote will be reported on a Form 8-K filed with the U.S. Securities and Exchange Commission.

The company serves consumers around the world with a portfolio of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. P&G operates in approximately 70 countries worldwide.

This news release does not mention the specifics of how the dividend or the voting results have changed since the last period. Following these announcements, the company's shares moved 0.3%, and are now trading at a price of $167.66. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS